Medicamen Biotech Limited — Glibenclamide Exporter Profile
Indian Pharmaceutical Exporter · #8 for Glibenclamide · $110.9K export value · DGFT Verified
Medicamen Biotech Limited is the #8 Indian exporter of Glibenclamide with $110.9K in export value and 11 verified shipments. Medicamen Biotech Limited holds a 0.3% market share in Glibenclamide exports across 8 countries. The company exports 8 pharmaceutical products worth $5.3M across 6 therapeutic categories.
Medicamen Biotech Limited — Glibenclamide Export Profile: Buyers & Destinations
Where Does Medicamen Biotech Limited Export Glibenclamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ETHIOPIA | $94.0K | 4 | 95.1% |
| ZIMBABWE | $3.0K | 1 | 3.0% |
| CAMEROON | $1.8K | 1 | 1.8% |
| COTE D IVOIRE | $0 | 1 | 0.0% |
| SENEGAL | $0 | 1 | 0.0% |
| TOGO | $0 | 1 | 0.0% |
| NIGER | $0 | 1 | 0.0% |
| MALI | $0 | 1 | 0.0% |
Medicamen Biotech Limited exports Glibenclamide to 8 countries. The largest destination is ETHIOPIA accounting for 95.1% of Medicamen Biotech Limited's Glibenclamide shipments, followed by ZIMBABWE (3.0%) and CAMEROON (1.8%). These destinations reflect Medicamen Biotech Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Glibenclamide from Medicamen Biotech Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | ETHIOPIA | $44.0K | 3 |
| PLANET PHARMACEUTICALS & CHEMICALS | ZIMBABWE | $3.0K | 1 |
| PHARMEZON SARL | CAMEROON | $1.8K | 1 |
| KEVOREH PHARMA SARL | COTE D IVOIRE | $0 | 1 |
| SHANIDAR PHARMA | SENEGAL | $0 | 1 |
| HK PHARMA SARL | TOGO | $0 | 1 |
| ADD PROMO | NIGER | $0 | 1 |
| M/S OMT INTERNATIONAL | MALI | $0 | 1 |
Medicamen Biotech Limited supplies Glibenclamide to 8 buyers globally. The largest buyer is TO THE ORDER OF (ETHIOPIA), followed by PLANET PHARMACEUTICALS & CHEMICALS (ZIMBABWE) and PHARMEZON SARL (CAMEROON). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Glibenclamide Export Value and How Much Does Medicamen Biotech Limited Contribute?
India exported $2.1M worth of Glibenclamide through 930 shipments from 194 suppliers to 100 countries, serving 335 buyers globally. Medicamen Biotech Limited contributes $110.9K to this total, accounting for 0.3% of India's Glibenclamide exports. Medicamen Biotech Limited ships Glibenclamide to 8 countries through 8 buyers.
What Is the Average Shipment Value for Medicamen Biotech Limited's Glibenclamide Exports?
Medicamen Biotech Limited's average Glibenclamide shipment value is $10.1K per consignment, based on 11 shipments totaling $110.9K. The largest destination is ETHIOPIA (95.1% of Medicamen Biotech Limited's Glibenclamide exports).
How Does Medicamen Biotech Limited Compare to Other Indian Glibenclamide Exporters?
Medicamen Biotech Limited ranks #8 among 194 Indian Glibenclamide exporters with a 0.3% market share. The top 3 exporters are MEDOPHARM ($420.3K), M. J. BIOPHARM PRIVATE LIMITED ($375.5K), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($274.9K). Medicamen Biotech Limited processed 11 shipments to 8 destination countries.
What Glibenclamide Formulations Does Medicamen Biotech Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GLIBENCLAMIDE TABLETS BP 5 MG.10 X10 EACH UNCOATED TABLET CONTAINS :GLIBENCLAMIDE BP 5 MG | $50.0K | 1 |
| GLIBENCLAMIDE TABLETS BP 5 MG 10X10,BATCH NO.NT50219 TO NT50223, MFG DT.01/03/2025, EXP DT.28/02/2028 | $34.6K | 1 |
| GLIBENCLAMIDE TABLETS BP 5 MG(10X10)EACH UNCOATED TAB. CONTAINS:GLIBENCLAMIDEBP 5 MG,B-NT50218,MFG-1-3-25,EXP-28-2-28 | $7.5K | 1 |
| GLIBENCLAMIDE TABLETS BP 5MG,BATCH NO.NT | $3.0K | 1 |
| GLIBENCLAMIDE TABLET BP 5 MG 10X10 BATCH NO NT50266 MFG DT 01 04 2025 EXP DT 31 03 2028 | $1.9K | 1 |
| GLIBENCLAMIDE TABLETS BP 5MG E.UNCOATED | $1.8K | 1 |
| GLIBEMED GLIBENCLAMIDE TAB.5MG B/N-NT203 | $0 | 1 |
| GLIBEMED 5MG GLIBENCLAMIDE TAB. BP B/N- | $0 | 1 |
| GLIBEMED 5MG GLIBENCLAMIDE TAB.BP 5 MG B | $0 | 1 |
| GLIBEMED (GLIBENCLAMIDE TAB.5MG) B/N-NT2 | $0 | 1 |
Medicamen Biotech Limited exports 11 distinct Glibenclamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GLIBENCLAMIDE TABLETS BP 5 MG.10 X10 EACH UNCOATED TABLET CO with 1 shipments worth $50.0K.
How Does Medicamen Biotech Limited Compare to Nearest Glibenclamide Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | LINCOLN PHARMACEUTICALS LTD | $124.9K | 16 | 5 | $7.8K |
| 7 | ZYDUS LIFESCIENCES LIMITED | $116.0K | 22 | 5 | $5.3K |
| 8 | MEDICAMEN BIOTECH LIMITED ★ | $110.9K | 11 | 8 | $10.1K |
| 9 | RUSAN PHARMA LIMITED | $107.8K | 3 | 1 | $35.9K |
| 10 | S KANT HEALTHCARE LIMITED | $104.7K | 12 | 4 | $8.7K |
Medicamen Biotech Limited ranks #8 among 194 Indian Glibenclamide exporters. Average shipment value of $10.1K compared to the market average of $11.0K. The closest competitors by value are LINCOLN PHARMACEUTICALS LTD and ZYDUS LIFESCIENCES LIMITED.
Which Indian Ports Ship Glibenclamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 133 | 14.3% |
| NHAVA SHEVA SEA (INNSA1) | 130 | 14.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 99 | 10.6% |
| JNPT/ NHAVA SHEVA SEA | 61 | 6.6% |
| JNPT | 45 | 4.8% |
| Bombay Air | 33 | 3.5% |
| MUNDRA SEA | 32 | 3.4% |
| AHEMDABAD ICD | 27 | 2.9% |
About Medicamen Biotech Limited
Medicamen Biotech Limited exports 8 products worth $5.3M. Beyond Glibenclamide, top products include Folic, Trimethoprim, Nystatin, Diphenhydramine, Sulfamethoxazole. View the complete Medicamen Biotech Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glibenclamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Glibenclamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medicamen Biotech Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 11 individual customs records matching Medicamen Biotech Limited exporting Glibenclamide, covering 11 formulations to 8 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 335+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Glibenclamide Export Data from Medicamen Biotech Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medicamen Biotech Limited's Glibenclamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medicamen Biotech Limited
Full Company Profile →
8 products · $5.3M total trade · 6 categories
Glibenclamide Stats
Company Overview
Top Products by Medicamen Biotech Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medicamen Biotech Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glibenclamide. For current shipment-level data, contact TransData Nexus.